These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Antithyroid drug-induced agranulocytosis: report of 13 cases. Huang CH; Li KL; Wu JH; Wang PN; Juang JH Chang Gung Med J; 2007; 30(3):242-8. PubMed ID: 17760275 [TBL] [Abstract][Full Text] [Related]
5. [Retrospective study of drug-induced agranulocytosis in hospitalized patients in Geneva and comparison with cases reported to IOCM]. Krayenbühl JC; Oestreicher MK; Sievering J; Stoller R; Dayer P Schweiz Med Wochenschr; 1998 Feb; 128(6):199-202. PubMed ID: 9540141 [TBL] [Abstract][Full Text] [Related]
6. Neutropenia and agranulocytosis in England and Wales: incidence and risk factors. van Staa TP; Boulton F; Cooper C; Hagenbeek A; Inskip H; Leufkens HG Am J Hematol; 2003 Apr; 72(4):248-54. PubMed ID: 12666135 [TBL] [Abstract][Full Text] [Related]
7. [Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance]. Llau ME; Nguyen L; Senard JM; Rascol O; Montastruc JL Rev Neurol (Paris); 1994 Nov; 150(11):757-62. PubMed ID: 7597368 [TBL] [Abstract][Full Text] [Related]
8. [Incidence and probable etiology of toxic agranulocytosis in a definite population in the province of Buenos Aires (1963-1976)]. Larregina A; Aggio MC; Alvarez RV Medicina (B Aires); 1994; 54(1):13-6. PubMed ID: 7990680 [TBL] [Abstract][Full Text] [Related]
9. Retrospective prevalence and incidence of drug-induced agranulocytosis in the city of São Paulo-Brasil. Hamerschlak N; Montezuma MP; Bacal N; Szterling LN; Rosenfeld LG; Guerra CC Rev Paul Med; 1993; 111(1):294-8. PubMed ID: 8235248 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial]. Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629 [TBL] [Abstract][Full Text] [Related]
11. [Movement disorders induced by drugs: experience at a pharmaco-vigilance center over five years]. Llau ME; Senard JM; Rascol O; Montastruc JL Therapie; 1995; 50(5):425-7. PubMed ID: 8571280 [TBL] [Abstract][Full Text] [Related]
15. Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS? Kang BJ; Cho MJ; Oh JT; Lee Y; Chae BJ; Ko J Hum Psychopharmacol; 2006 Aug; 21(6):387-91. PubMed ID: 16933201 [TBL] [Abstract][Full Text] [Related]
16. Hematopoietic growth factors in drug-induced agranulocytosis. Pavithran K; Thomas M J Assoc Physicians India; 2002 May; 50(5):679-81. PubMed ID: 12186123 [TBL] [Abstract][Full Text] [Related]
17. [Agranulocytosis as a complication of acute infectious mononucleosis]. Brkić S; Aleksić-Dordević M; Belić A; Jovanović J; Bogdanović M Med Pregl; 1998; 51(7-8):355-8. PubMed ID: 9769672 [TBL] [Abstract][Full Text] [Related]
18. Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Hedenmalm K; Spigset O Eur J Clin Pharmacol; 2002 Jul; 58(4):265-74. PubMed ID: 12136373 [TBL] [Abstract][Full Text] [Related]
19. Blood dyscrasias induced by psychotropic drugs. Stübner S; Grohmann R; Engel R; Bandelow B; Ludwig WD; Wagner G; Müller-Oerlinghausen B; Möller HJ; Hippius H; Rüther E Pharmacopsychiatry; 2004 Mar; 37 Suppl 1():S70-8. PubMed ID: 15052517 [TBL] [Abstract][Full Text] [Related]
20. Causes of agranulocytosis in a hospital population: identification of dipyrone as an important causative agent. Shinar E; Hershko C Isr J Med Sci; 1983 Mar; 19(3):225-9. PubMed ID: 6853118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]